Viking Global Investors
BMY.RT

Viking Global Investors’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Viking Global Investors’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,825,899
Closed -$6.09M – 124
2020
Q4 		$6.09M Sell
8,825,899
-9,575,370
-52% -$20.4M 0.02% 96
2020
Q3 		$41.4M Sell
18,401,269
-566,750
-3% -$1.62M 0.15% 75
2020
Q2 		$67.9M Sell
18,968,019
-671,182
-3% -$2.42M 0.29% 60
2020
Q1 		$74.6M Sell
19,639,201
-6,364,383
-24% -$21M 0.39% 49
2019
Q4 		$78.3M Buy
+26,003,584
New +$67.6M 0.37% 44

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Viking Global Investors's BMY.RT Position: Q1 2021 in Review

Viking Global Investors sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 8,825,899 shares — an estimated $6.09M sold.

Viking Global Investors first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $78.3M in Q4 2019. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Viking Global Investors reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Viking Global Investors sold 8,825,899 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $6.09M.
  • Viking Global Investors first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Viking Global Investors's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $78.3M in Q4 2019.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Viking Global Investors's 13F filing for Q1 2021, filed 17 May 2021.